Jon H Come

3PUBLICATIONS
49CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 10, 2026
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Anti-Tumor Immunity and Immunotherapy Efficacy.

|Jan 27, 2025
LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers.

Lauren Catherine M Martires, Leanne G Ahronian, Charlotte B Pratt

|Apr 08, 2024
Massively parallel combination screen reveals small molecule sensitization of antibiotic-resistant Gram-negative ESKAPE pathogens.

Megan W Tse, Meilin Zhu, Benjamin Peters

Pageof 1

Frequent Collaborators

2 joint publications

Laura L Kiessling

2 joint publications

William D Mallender

2 joint publications

Douglas A Whittington

2 joint publications

Hongxiang Zhang